AbCellera to Report Full Year 2021 Financial Results on February 24, 2022
AbCellera (Nasdaq: ABCL) will report its full year 2021 financial results on February 24, 2022, after market close. The earnings conference call will commence at 2:00 p.m. PT (5:00 p.m. ET), with a live webcast available on AbCellera’s Investor Relations website. The company specializes in antibody development, partnering with various drug developers to enhance drug development efficiency.
- Upcoming earnings report may provide insights into financial performance and growth.
- The company partners with both large and small drug developers, showcasing a broad market appeal.
- None.
The live webcast of the earnings conference will be available through a link that will be posted on AbCellera’s Investor Relations website. A replay of the webcast will be available through the same link following the conference call.
About
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. To learn more, visit www.abcellera.com.
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20220126005945/en/
Media:
Investor Relations:
Source: AbCellera
FAQ
When will AbCellera report its 2021 financial results?
What time is AbCellera's earnings conference call?
Where can I access the webcast for AbCellera's earnings call?